Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125350761 | 12535076 | 1 | I | 20160627 | 20160707 | 20160707 | EXP | US-TEVA-673210USA | TEVA | JACOBSEN A, PAPO Y, SARRO R, WEISSE K, STRASSWIMMER J. POSACONAZOLE SUBSTITUTION FOR VORICONAZOLE-ASSOCIATED PHOTOCARCINOGENESIS. J-INVEST-DERMATOL 2016;136 (SUPPL. 1)(5):S103. | 0.00 | E | F | Y | 0.00000 | 20160707 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125350761 | 12535076 | 1 | PS | VORICONAZOLE. | VORICONAZOLE | 1 | Unknown | U | 91658 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125350761 | 12535076 | 1 | Meningitis fungal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125350761 | 12535076 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125350761 | 12535076 | Actinic keratosis | |
| 125350761 | 12535076 | Photosensitivity reaction | |
| 125350761 | 12535076 | Squamous cell carcinoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |